VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Showed up in my google news feed

<< Previous

Bullboard Posts

Next >>

Comment by Gdangiton Jan 31, 2021 8:37am

101 Views

Post# 32430784

RE:RE:RE:RE:RE:RE:Showed up in my google news feed

kings college was a freebie test. It was placed so the could add hype because there was no sales and his share price was in the gutter. That's why the cheesy webinar videos, that's why the freebie to kings college in London open your eyes. This product should be doubling production and quadrupling sales bi weekly. He has too much competition and true fully his product can't be all that and a bag of chips. With all the covid patients with heart problems I'm pretty sure the vms3.0 would overpass the security reasoning for placement to help save lives in the hospitals world wide.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December